Status:
RECRUITING
An Integrated Neurophysiological Approach Toward the Early Detection of Psychiatric Disorders
Lead Sponsor:
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Collaborating Sponsors:
University of Bologna
Conditions:
Schizophrenia Disorders
Eligibility:
All Genders
18-50 years
Brief Summary
Schizophrenia (SCZ) is a severe neuropsychiatric disorder characterized by cognitive decline, social withdrawal, and positive symptoms such as hallucinations and delusions. Research suggests that SCZ ...
Detailed Description
Schizophrenia (SCZ) is among the most debilitating syndromes within the neuropsychiatric domain, with patients suffering from this condition displaying a rich nosographic characterization. Besides, an...
Eligibility Criteria
Inclusion
- Inclusion Criteria (all participants):
- Normal hearing
- Normal or corrected-to-normal vision
- Inclusion Criteria (patients):
- Clinical diagnosis of schizophrenia spectrum disorder (according to DSM-5)
- IQ \> 70
- Exclusion Criteria (all participants):
- Anamnesis or evidence of any central nervous system alteration
- Exclusion Criteria (patients)
- Current major physical illness
- Drug dependency/abuse over the last 6 months
- Unstable pharmacological therapy
- Comorbidities with other major psychiatric disorders
Exclusion
Key Trial Info
Start Date :
April 9 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT06886945
Start Date
April 9 2024
End Date
October 1 2025
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Brescia, BS, Italy, 24125